PacBio Q4 Revenues Climb 85 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Pacific Biosciences reported today after the close of the market that its fourth quarter 2014 revenues spiked 85 percent year over year.

The Menlo Park, Calif.-based single-molecule sequencing technology firm reported Q4 2014 revenues of $16.9 million, up from $9.1 million in the prior-year period, beating the consensus analyst estimate of $14.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.